Skip to main content
. 2012 Feb 1;18(2):BR76–BR83. doi: 10.12659/MSM.882460

Figure 10.

Figure 10

The measured parameters changed in a group of COPD patients before and after Hypoxen® treatment and at acute attack by 54% without HyFnC60 (1st bar). In presence of HyFn (10−6 and 10−19 M) in blood of these patients – by 77 and 64% (2nd and 3th bars). Kinetic CL parameters of COPD patients blood before and after Hypoxen® treatment can be discriminated with the probability of 72, 85 and 83% (4th, 5th and 6th bars respectively). The results of the 5th bar were obtained in presence of 10−6 M HyFnC60, 6th contained 10−19 M HyFnC60.